nach oben

Reactions Weekly

Erschienen in:

01.03.2024 | Case report

Secukinumab

Various toxicities and lack of efficacy following off label use

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Fernandez-Crehuet P, et al. Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study. Dermatology and Therapy 13: 1029-1038, No. 4, Apr 2023. Available from: URL: https://www.springer.com/journal/13555

Titel: Secukinumab
Various toxicities and lack of efficacy following off label use
Publikationsdatum: 01.03.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-54281-2

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Doxorubicin/pembrolizumab

Unspecified bronchodilators/Magnesium/unspecified Steroids

Ipilimumab and nivolumab

Antineoplastics/cotrimoxazole/folinic-acid

Sorafenib

Multiple drugs